Great Lakes Advisors LLC Invests $5.17 Million in Corteva, Inc. $CTVA

Great Lakes Advisors LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, Holdings Channel reports. The fund purchased 61,037 shares of the company’s stock, valued at approximately $5,169,000.

Several other hedge funds have also added to or reduced their stakes in CTVA. BlackRock Inc. acquired a new stake in Corteva in the second quarter worth about $4,560,180,000. Harris Associates L P lifted its position in Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the period. Norges Bank bought a new position in shares of Corteva in the 4th quarter valued at about $504,001,000. Royal Bank of Canada grew its position in shares of Corteva by 202.1% during the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after buying an additional 4,989,371 shares during the period. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Corteva during the 2nd quarter worth approximately $392,447,000. Institutional investors own 81.54% of the company’s stock.

Analysts Set New Price Targets

CTVA has been the subject of several recent research reports. Royal Bank Of Canada upped their target price on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research report on Tuesday, July 21st. Mizuho lifted their price target on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. UBS Group lowered their price target on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research note on Tuesday. Finally, BMO Capital Markets increased their price objective on Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Price Performance

Shares of NYSE CTVA opened at $78.51 on Thursday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The firm has a market cap of $52.38 billion, a P/E ratio of 51.99, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. The business’s 50 day moving average is $81.92 and its 200-day moving average is $80.15.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the previous year, the business posted $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is currently 47.68%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.